Liquidia Technologies (NASDAQ:LQDA) is set to announce its earnings results before the market opens on Thursday, August 8th. Analysts expect the company to announce earnings of ($0.57) per share for the quarter.
Shares of Liquidia Technologies stock traded up $0.36 during trading on Tuesday, reaching $6.27. 31,645 shares of the company’s stock were exchanged, compared to its average volume of 40,232. The company has a current ratio of 5.57, a quick ratio of 5.57 and a debt-to-equity ratio of 0.46. Liquidia Technologies has a 1-year low of $5.82 and a 1-year high of $38.46. The stock has a market cap of $118.38 million and a P/E ratio of -0.83. The company has a 50-day simple moving average of $7.85.
A number of equities analysts have recently commented on LQDA shares. Zacks Investment Research cut Liquidia Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, May 8th. Wedbush reissued a “buy” rating and set a $50.00 price target on shares of Liquidia Technologies in a report on Friday, June 28th. Finally, ValuEngine raised Liquidia Technologies from a “hold” rating to a “buy” rating in a report on Thursday, August 1st. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $31.80.
Liquidia Technologies Company Profile
Liquidia Technologies, Inc, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension.
Recommended Story: What is a Roth IRA?
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.